Application

17772187 · DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINE

Filed 2022-04-27 · Pending The official file ↗ · Art unit 1616 · Examiner Mina Haghighatian Typical · CPC A61K 9/0075 · AstraZeneca AB · ASTRAZENECA MEDIMMUNE

Office actions

first was Restriction requirement

RCEs

appealed

To first action

37.3 mo

to disposition n/a

Statutes raised

102 103 112

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.